News

Under the terms of the deal, KineMed will screen numerous molecules provided by the library of Sosei’s drug reprofiling platform (DRP) using its proprietary in vivo KineMarker assays.

The co-promotion agreement provides that Kos and Duramed Pharmaceuticals, a subsidiary of Barr, will co-promote the current Niaspan and Advicor products, as well as future dosage formulations, strengths

Celadrin, developed by Imagenetix, is a proprietary fatty acid complex useful in promoting joint health. It has been approved for use as a pharmaceutical product in India to

Evotec OAI has a long-standing relationship with Roche. In 2004, the companies signed a substantial medicinal chemistry agreement, supporting four Roche sites in the design and synthesis of

Perlegen intends to apply its leading whole genome pharmacogenomics technology to improve upon the demonstrated efficacy and safety profile of MCC-555 (a peroxisome proliferator activated receptor, or PPAR,

Under the agreement, Alnylam will provide Benitec and its licensees an option to non-exclusively license Alnylam-controlled intellectual property (IP) in the field of expressed RNA interference (RNAi): targeted

These findings are important because several commonly prescribed anti-epileptic drugs (AEDs) may reduce the effectiveness of oral contraceptives, a potentially serious drug interaction for some women with epilepsy.

Vaccinia immune globulin (VIGIV) is used to treat rare serious reactions that sometimes occur with smallpox vaccination. The hyperimmune plasma will be supplied by Life Sera, an Atlanta-based

Osmotics Pharma Inc (OPI) is an emerging specialty pharmaceutical company focused on developing prescription products for the treatment of various dermatological disorders, antibiotic-resistant strains of bacteria and certain